$864 Million is the total value of BRIDGER MANAGEMENT, LLC's 36 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
REGN | New | REGENERON PHARMACEUTICALS | $44,824,000 | – | 91,797 | +100.0% | 5.19% | – |
UNH | New | UNITEDHEALTH GROUP INC | $36,755,000 | – | 147,384 | +100.0% | 4.25% | – |
INCY | New | INCYTE CORP | $31,248,000 | – | 426,708 | +100.0% | 3.62% | – |
HRC | New | HILL ROM HLDGS INC | $19,157,000 | – | 190,426 | +100.0% | 2.22% | – |
IRWD | New | IRONWOOD PHARMACEUTICALS INC | $15,585,000 | – | 1,544,590 | +100.0% | 1.80% | – |
LH | New | LABORATORY CORP AMER HLDGS | $14,049,000 | – | 111,157 | +100.0% | 1.63% | – |
ARNA | New | ARENA PHARMACEUTICALS INC | $7,635,000 | – | 181,786 | +100.0% | 0.88% | – |
CZR | New | CAESARS ENTMT CORP | $6,013,000 | – | 889,497 | +100.0% | 0.70% | – |
QTRX | New | QUANTERIX CORP | $5,579,000 | – | 303,703 | +100.0% | 0.65% | – |
ERI | New | ELDORADO RESORTS INCcall | $3,600,000 | – | 250,000 | +100.0% | 0.42% | – |
FWONK | New | LIBERTY MEDIA CORP DEL | $3,171,000 | – | 116,440 | +100.0% | 0.37% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.